independence: luspatercept vs placebo in mpns-associated myelofibrosis
Published 3 years ago • 98 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:37
phase iii independence trial of luspatercept in patients with td myelofibrosis on jaki therapy
-
3:12
transfusion independence and momelotinib in myelofibrosis
-
1:30
the association between transfusion independence and improved survival in myelofibrosis
-
2:30
medalist: luspatercept and erythropoiesis biomarkers in mds
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
1:30:39
smpte essential technology conepts: human perception fundamentals: color, contrast, and motion
-
6:31
the current treatment landscape for polycythemia vera
-
2:44
myelofibrosis: jenson shares his experience
-
3:36
mpns as discrete subtypes
-
2:55
mpns: a changing treatment landscape
-
2:43
the management of advanced phase mpns
-
2:29
future treatment strategies for mpns
-
1:39
treating patients with myelofibrosis who are intolerant to or develop resistance to jak inhibitors
-
1:58
transfusion-independence associated with os in simplify-1 and simplfy-2
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
2:39
treating and managing blast-phase mpns: a major unmet need
-
0:25
aesculap® structan - augments for acetabular revision
-
1:42
dr. jon weyer explains: what is presbyopia?
-
4:39
imetelstat shows promise in advanced myelofibrosis
-
1:32
blast-phase mpns: a major unmet need in the field
-
1:57
what does vision look like with presbyopia? | animation